Nice to see Board members buying shares "MPXI" or the "Company") (CSE:MPXI)(OTCPINK:MPXOF) today announced that W. Scott Boyes, Chairman, CEO and President of MPXI, and Randall Stafford, a Director of MPXI, have, during the month of October 2019, executed open-market purchases of an aggregate of 1,271,000 common shares of MPXI (the "MPXI Shares") for the aggregate purchase price of CDN$597,094.
Mr. Boyes purchased 800,000 MPXI Shares with an average cost of CDN$0.482 per MPXI Share for a total purchase amount of CDN$385,788. Mr. Stafford has acquired 471,150 MPXI Shares at an average of CDN$0.448 per MPXI Share for a total purchase price of CDN$211,306.
"We continue to be very excited about the rapidly emerging global medical cannabis marketplace," commented Mr. Boyes. "With over 35 countries having now legalized medical cannabis, the industry is entering a phase of rapid international expansion and, as MPXI continues to develop its operations in the UK, Malta, Switzerland, Australia, South Africa, Canada and elsewhere, I am ever-more confident that our company is well-positioned for near-term growth and profitability and for the creation of long-term value for its shareholders."